Phase III Randomized, Double-Blind, Placebo-Controlled Study of Finasteride (Proscar) for the Chemoprevention of Prostate Cancer

Trial Profile

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Finasteride (Proscar) for the Chemoprevention of Prostate Cancer

Discontinued
Phase of Trial: Phase III

Latest Information Update: 05 Oct 2015

At a glance

  • Drugs Finasteride (Primary)
  • Indications Prostate cancer; Prostatic intraepithelial neoplasia
  • Focus Therapeutic Use
  • Acronyms PCPT
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 15 Aug 2013 Primary endpoint 'Disease-occurrence-rate' has been met.
    • 15 Aug 2013 Results after 18 years of follow-up published in the New England Journal of Medicine.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top